Showing results (11-20 of 294) with videos related to
Sort By:
Pageof 30
Revue Medicale Suisse|May 12, 2006
[Generic drugs and legal incentives: which impact?]F Livio, T Buclin, A Pannatier, et al.Revue Medicale Suisse|May 12, 2006
[Risk of overtreatment: not to be neglected. The example of antiepileptic drugs]L E Rothuizen, T Buclin, M Reichhart, et al.Clinical Pharmacokinetics|January 1, 1997
Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonistsC Csajka, T Buclin, H R Brunner, et al.British Journal of Clinical Pharmacology|January 22, 2003
NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratiosA Nyéki, T Buclin, J Biollaz, et al.Drugs|January 1, 1993
Renal effects of nimesulide in furosemide-treated subjectsF Steinhäuslin, A Munafo, T Buclin, et al.British Journal of Clinical Pharmacology|December 3, 1999
Evaluation of noninvasive blood pressure recording by photoplethysmography in clinical studies using angiotensin challengesT Buclin, C Buchwalder-Csajka, H R Brunner, et al.British Journal of Clinical Pharmacology|December 3, 1999
Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin systemC Buchwalder-Csajka, T Buclin, H R Brunner, et al.Revue Medicale Suisse|February 23, 2010
[Pharmacovigilance update]F Livio, A Ivanyuk, J Biollaz, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2000
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractionC Marzolini, A Telenti, T Buclin, et al.Therapeutic Drug Monitoring|July 31, 2001
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variabilityC Marzolini, T Buclin, L A Decosterd, et al.Pageof 30